Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) - Total Liabilities
Based on the latest financial reports, Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) has total liabilities worth CN¥992.87 Million CNY (≈ $145.29 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Shandong Weigao Orthopaedic Device Co. L to assess how effectively this company generates cash.
Shandong Weigao Orthopaedic Device Co. Ltd. A - Total Liabilities Trend (2019–2024)
This chart illustrates how Shandong Weigao Orthopaedic Device Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Check 688161 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Shandong Weigao Orthopaedic Device Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Shandong Weigao Orthopaedic Device Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cohu Inc
NASDAQ:COHU
|
USA | $457.44 Million |
|
Qinchuan Machine Tool & Tool Group Share Co Ltd
SHE:000837
|
China | CN¥4.36 Billion |
|
Predictive Discovery Ltd
AU:PDI
|
Australia | AU$6.91 Million |
|
Jindal Saw Limited
NSE:JINDALSAW
|
India | Rs93.77 Billion |
|
Arcelik AS
IS:ARCLK
|
Turkey | TL467.63 Billion |
|
Zhuzhou Times New Material Technology Co Ltd
SHG:600458
|
China | CN¥18.32 Billion |
|
Cyrela Brazil Realty S.A. Empreendimentos e Participações
SA:CYRE3
|
Brazil | R$13.46 Billion |
|
BIEM.L .FDLKK Garment Co Ltd
SHE:002832
|
China | CN¥1.89 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Shandong Weigao Orthopaedic Device Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688161 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Weigao Orthopaedic Device Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Weigao Orthopaedic Device Co. Ltd. A (2019–2024)
The table below shows the annual total liabilities of Shandong Weigao Orthopaedic Device Co. Ltd. A from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥984.79 Million ≈ $144.11 Million |
-19.44% |
| 2023-12-31 | CN¥1.22 Billion ≈ $178.88 Million |
+21.08% |
| 2022-12-31 | CN¥1.01 Billion ≈ $147.74 Million |
+16.64% |
| 2021-12-31 | CN¥865.64 Million ≈ $126.67 Million |
+19.76% |
| 2020-12-31 | CN¥722.79 Million ≈ $105.77 Million |
-45.81% |
| 2019-12-31 | CN¥1.33 Billion ≈ $195.18 Million |
-- |
About Shandong Weigao Orthopaedic Device Co. Ltd. A
Shandong Weigao Orthopaedic Device Co., Ltd. operates as a orthopedic implant medical device and pharmaceutical company. The company offers general consumables, such as clinical care consumables and supplies, infection protection supplies, infusion consumables, indwelling needle, anesthesia respiratory consumables, other operating room consumables, and other clinical consumables; endocrine consum… Read more